Research projects on immunotherapy
Immunotherapy is becoming an effective treatment for various type of cancers. Therefore, VRISG is strategically applying technologies to produce Natural Killer Cells, Dendritic Cells, T cells or CAR-T cells for cancer treatment. The further studies will focus on research and application of immune cell therapy in treatment of autoimmune diseases with high clinical demand such as arthritis and lupus.
Projects |
Technology development for CAR-T cell therapy to treat hematologic cancers |
To identify the autoantigens and autoreactive T cells for narcolepsy type I |